Deep Intelligence Across Industries

Kimberly-Clark is a 154-year-old maker of essential absorbent, tissue and hygiene products. With the Kenvue acquisition it has become one of the world's largest consumer health and wellness companies. On fiscal 2025 figures recast to the new structure, combined annual sales are about $31.6 billion, and the portfolio includes ten brands with more than $1 billion each in annual sales: Huggies, Kleenex, Cottonelle, Scott, Depend, Kotex, Tylenol, Listerine, Neutrogena and Johnson's Baby. Before the deal, the group had already moved its portfolio toward personal care. It sold its personal protective equipment business to Ansell (2024), exited US private-label diapers, and placed its international tissue business into the Arbex joint venture with Suzano, keeping a 49% stake (closed July 2026). Its competitive edge rests on nonwovens and absorbency science, No. 1 or No. 2 share positions in about 70 countries, and a productivity engine that saves about 6% of cost of goods each year. The main open questions are execution: integrating Kenvue, capturing about $2.1 billion of targeted synergies, cutting leverage after the debt-funded cash portion, and managing Kenvue's inherited acetaminophen and talc litigation. In the semiconductor supply chain, Kimberly-Clark Professional remains a recognised supplier of cleanroom wipers (Kimtech Pure W4, W5 and Kimtech Prep ScottPure). Its cleanroom gloves and apparel went to Ansell in 2024. --- ### Company description (FY2025 Form 10-K) The FY2025 Form 10-K describes Kimberly-Clark as a global company focused on products that provide "better care for a better world." It makes and markets products from natural or synthetic fibres using nonwovens and absorbency technologies. Products are sold in more than 175 countries and territories, under brands that hold No. 1 or No. 2 share positions in about 70 countries. At year-end 2025 the company ran 74 manufacturing facilities in 30 countries, including equity affiliates: 27 in North America across 14 US states and 47 elsewhere. ### Business model and revenue model | Revenue mix dimension | Approximate share (continuing operations, FY2025) | |---|---| | Product sales | ~99% | | Licensing / royalties | Immaterial (rising from 2026 via Arbex brand licences) | | Services (e.g., Professional dispenser programmes) | Immaterial, bundled with product | | Largest customer (Walmart Inc.) | ~16% of continuing net sales (FY2025 and FY2024) | | United States | $10.1 billion of $16.4 billion (~61%) | The business sells branded physical products. Revenue comes from product sales to retailers (mass merchants, grocery, drug, club, e-commerce), to distributors (the Professional business), and to healthcare channels. Subscription, licensing and service revenue are immaterial. There are two exceptions. Royalty-type licensing income will come from Arbex, which licenses the Kleenex, Scott and Viva names outside the United States. Equity income comes from affiliates such as Kimberly-Clark de Mexico, Yuhan-Kimberly in South Korea, and now Arbex. Income from equity companies was $196 million in FY2025. Guidance for 2026 calls for about a 30% increase, mostly because of Arbex. **Product sales:** Approximate share (continuing operations, FY2025): ~99% **Licensing / royalties:** Approximate share (continuing operations, FY2025): Immaterial (rising from 2026 via Arbex brand licences) **Services (e.g., Professional dispenser programmes):** Approximate share (continuing operations, FY2025): Immaterial, bundled with product **Largest customer (Walmart Inc.):** Approximate share (continuing operations, FY2025): ~16% of continuing net sales (FY2025 and FY2024) **United States:** Approximate share (continuing operations, FY2025): $10.1 billion of $16.4 billion (~61%) ### Value-chain position Kimberly-Clark is vertically integrated from fibre processing through branded marketing. It buys pulp and superabsorbent polymer and polypropylene/polyethylene resins, makes nonwovens and absorbent cores in-house, and converts them into finished goods. In tissue it has deliberately de-verticalised outside North America through the Arbex joint venture, reducing its exposure to pulp-price swings. Kenvue adds an over-the-counter (OTC) drug and topical-formulation value chain: contract and owned API sourcing, pharmaceutical-grade manufacturing, and healthcare-professional detailing. ### Customer types and end markets | Customer / end market | Products | Notes | |---|---|---| | Mass retail and grocery (consumers) | Diapers, training pants, wipes, bath tissue, paper towels, facial tissue, feminine and adult care | Core channel; Walmart about 16% of sales | | E-commerce | All consumer categories | Fast-growing channel, especially in China and the US | | Away-from-home (Professional) | Washroom towels and tissue, WypAll wipers, Kimtech wipers, Scott hand-care | Distributor-led; US business retained by Kimberly-Clark | | Scientific and cleanroom (semiconductor fabs, pharma fill-finish, laboratories) | Kimtech Pure W4 pre-saturated IPA wipers, Kimtech Pure W5, Kimtech Prep ScottPure, Kimtech Science Kimwipes | W4 is pre-saturated with 70% semiconductor-grade isopropyl alcohol and 30% deionised water and is rated for ISO Class 4 environments. W5 is rated for ISO Class 5 (Class 100). | | Healthcare and pharmacy (from November 2026) | Tylenol, Motrin, Zyrtec (US), Listerine, Band-Aid, Neutrogena, Aveeno, Johnson's | Added through Kenvue; HCP-recommended brands | **Mass retail and grocery (consumers):** Products: Diapers, training pants, wipes, bath tissue, paper towels, facial tissue, feminine and adult care; Notes: Core channel; Walmart about 16% of sales **E-commerce:** Products: All consumer categories; Notes: Fast-growing channel, especially in China and the US **Away-from-home (Professional):** Products: Washroom towels and tissue, WypAll wipers, Kimtech wipers, Scott hand-care; Notes: Distributor-led; US business retained by Kimberly-Clark - **Scientific and cleanroom (semiconductor fabs, pharma fill-finish, laboratories)** — Products: Kimtech Pure W4 pre-saturated IPA wipers, Kimtech Pure W5, Kimtech Prep ScottPure, Kimtech Science Kimwipes; Notes: W4 is pre-saturated with 70% semiconductor-grade isopropyl alcohol and 30% deionised water and is rated for ISO Class 4 environments. W5 is rated for ISO Class 5 (Class 100). **Healthcare and pharmacy (from November 2026):** Products: Tylenol, Motrin, Zyrtec (US), Listerine, Band-Aid, Neutrogena, Aveeno, Johnson's; Notes: Added through Kenvue; HCP-recommended brands ### Independent characterisation Before the Kenvue deal, Kimberly-Clark was a mature, cash-generative US hygiene company. It had spent three years trimming lower-margin assets (PPE, private-label diapers, international tissue) and reinvesting in innovation and productivity under its "Powering Care" strategy. The Kenvue acquisition changes the profile. The combined company has about 57% of sales in North America on the new segment map. It moves into higher-gross-margin consumer health: Kenvue's FY2025 adjusted gross margin was about 60%, against Kimberly-Clark's 37%. It also takes on a new set of risks: pharmaceutical regulation, product-liability litigation and much higher debt. For the semiconductor supply chain the relevant business is small: high-purity cleanroom wiping consumables sold mainly through distributors such as Fisher Scientific, Avantor/VWR and TestEquity. It is a non-core but reputationally established niche.